Triptans: the original migraine-specific medication.

Triptans are a class of acute migraine medications first introduced in 1991 with the launch of sumatriptan. Before triptans, patients took whatever was available — opioids, ergots, painkillers — most of which weren’t designed for migraine and didn’t work particularly well for it. Triptans changed that.

For thirty years, triptans have been the standard acute treatment for migraine. They remain highly effective for many patients today, and they’re typically the first prescription acute medication a clinician will recommend.

There are seven triptans currently FDA-approved in the United States:

• Sumatriptan (Imitrex) — the original, available as pill, nasal spray, or injection
• Rizatriptan (Maxalt) — fast-acting, available as a dissolvable tablet
• Zolmitriptan (Zomig) — pill or nasal spray
• Eletriptan (Relpax) — known for strong efficacy in clinical trials
• Almotriptan (Axert) — well-tolerated, often used for sensitive patients
• Naratriptan (Amerge) — slower onset but longer-lasting
• Frovatriptan (Frova) — longest-lasting, often used for menstrual migraine

All seven work through the same general mechanism, but they don’t behave identically. A patient who doesn’t respond to one triptan may respond very well to another — a fact that often surprises patients who have been told “triptans don’t work for me” after trying just one.

Triptans bind to specific serotonin receptors in the brain — the 5-HT1B and 5-HT1D receptors — which has two main effects during a migraine attack.

The combined effect is the interruption of an active migraine — often within 30 to 90 minutes of taking the medication. Triptans work best when taken at the very first sign of an attack: ideally during the aura phase before the headache begins, or within the first hour of pain.

The phrase patients often use is “catching it early.” That’s clinically accurate — the earlier in the attack a triptan is taken, the more effectively it works.

Triptans are FDA-approved for the acute treatment of migraine in adults. They’re a particularly good fit for:

For patients in any of these categories, gepants (Nurtec, Ubrelvy) are typically the better acute treatment — they target the CGRP pathway without the vascular effects.

The Wellday assessment screens for cardiovascular contraindications carefully. Many patients who think they can’t take triptans actually can; many who think they can shouldn’t. A clinician should make that call.

Taking a triptan. Most triptans come as pills, though several are also available as nasal sprays or injections. Pill formulations work well for most patients; nasal sprays and injections are useful for patients whose migraines come with severe nausea or vomiting that makes pills hard to keep down. Sumatriptan injections work fastest of all — typically within 10–15 minutes — but most patients only need them in specific circumstances.

The timeline. Pain relief typically begins within 30 minutes and reaches full effect within 1–2 hours. About 60% of patients report meaningful relief within 2 hours of taking the right triptan at the right time. If pain returns later in the day (called “headache recurrence”), a second dose can usually be taken — typically 2 hours after the first.

The “right triptan” matters. This is the part that surprises many patients: triptans aren’t interchangeable. Sumatriptan works very differently from naratriptan, which works differently from eletriptan. If your first triptan didn’t work — or worked but caused side effects you couldn’t live with — that’s not a verdict on triptans as a class. It’s a signal to try a different one.

What the experience looks like for a typical responder

That’s what acute treatment is supposed to look like. Many patients have never experienced it because they’ve only tried OTC pain medications, which work very differently.

Triptans are well-studied — they have thirty years of real-world use. The most commonly reported side effects:

Most of these are mild and resolve within an hour or two. The chest-tightness sensation is the one that most often worries patients — it’s typically not cardiac-related, but if it’s significant, it’s worth discussing with your clinician.

Important warnings

• Triptans should not be combined with each other, or used within 24 hours of an ergotamine medication
• Patients on certain antidepressants (SSRIs, SNRIs) need clinical review before starting triptans — combinations can occasionally trigger serotonin syndrome
• Triptans can occasionally raise blood pressure — patients with hypertension should be monitored

Medication overuse: Like all acute migraine medications, triptans can cause “medication overuse headache” if taken more than 10 days per month. This is one of the strongest signals that you need a preventive medication, not just more acute treatment.

Triptans are generic, well-understood, and significantly cheaper than newer medications. Most don’t require prior authorization. The main barriers to access aren’t insurance — they’re getting a clinician to spend the time figuring out which triptan is the best fit for your pattern.